Impact of Sirolimus-Eluting Stent Fracture on 4-Year Clinical Outcomes | Zendy

Hisashi Umeda | Zendy; Tomoko Kawai | Zendy; Naoki Misumida | Zendy; Tomoyuki Ota | Zendy; Kazutaka Hayashi | Zendy; Mitsunori Iwase | Zendy; Hideo Izawa | Zendy; Shigeo Sugino | Zendy; Takeshi Shimizu | Zendy; Yasushi Takeichi | Zendy; Ryoji Ishiki | Zendy; Haruo Inagaki | Zendy; Yukio Ozaki | Zendy; Toyoaki Murohara | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact of Sirolimus-Eluting Stent Fracture on 4-Year Clinical Outcomes

Author(s) -

Hisashi Umeda,

Tomoko Kawai,

Naoki Misumida,

Tomoyuki Ota,

Kazutaka Hayashi,

Mitsunori Iwase,

Hideo Izawa,

Shigeo Sugino,

Takeshi Shimizu,

Yasushi Takeichi,

Ryoji Ishiki,

Haruo Inagaki,

Yukio Ozaki,

Toyoaki Murohara

Publication year - 2011

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.110.958306

Subject(s) - mace , medicine , restenosis , stent , sirolimus , lesion , cardiology , drug eluting stent , surgery , myocardial infarction , percutaneous coronary intervention

Although stent fracture (SF) after sirolimus-eluting stent (SES) implantation has been recognized as one of the predisposing factors of in-stent restenosis, it remains uncertain whether SF can increase the risk of major adverse cardiac events (MACE), especially beyond 1 year after SES implantation. The aim of this study was to assess the impact of SF relative to non-SF on 4-year clinical outcomes after treatment with SES of comparable unselected lesions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research